NCT06386445View on ClinicalTrials.gov

Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Stem Cell Transplant ComplicationsAcute Graft Versus Host DiseaseAcute Kidney InjuryMajor Adverse Cardiac Events

Interventions

OTHER

Serum metabolomics sequencing

Serum samples from the day before pre-treatment, day after pre-treatment, 2 weeks，4 weeks，8 weeks and 12 weeks after transplantation will be detected by metabolomics sequencing.

All Listed Sponsors

lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT06386445 - Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study | Biotech Hunter | Biotech Hunter